Literature DB >> 15814712

Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection.

Bernadette M Saunders1, Stephen Tran, Sigrid Ruuls, Jonathon D Sedgwick, Helen Briscoe, Warwick J Britton.   

Abstract

TNF is critical for immunity against Mycobacterium tuberculosis infection; however, the relative contributions of the soluble and transmembrane forms of TNF in this immunity are unknown. Using memTNF mice, which express only the transmembrane form of TNF, we have addressed this question. Wild-type (WT), TNF-/-, and transmembrane TNF (memTNF) mice were infected with M. tuberculosis by aerosol. TNF-/- mice developed overwhelming infection with extensive pulmonary necrosis and died after only 33 days. memTNF mice, like WT mice, contained bacterial growth for over 16 wk, developed an Ag-specific T cell response, and initially displayed compact granulomas, comprised of both lymphocytes and macrophages. Expression of mRNA for the chemokines CXCL10, CCL3, CCL5, and CCL7 was comparable in both WT and memTNF mice. As the infection progressed, however, the pulmonary lesions in memTNF mice became larger and more diffuse, with increased neutrophil accumulation and necrosis. This was accompanied by increased influx of activated memory T cells into the lungs of memTNF mice. Eventually, these mice succumbed to infection with a mean time to death of 170 days. The expression of memTNF on T cells is functionally important because the transfer of T cells from memTNF, but not TNF-/- mice, into either RAG-/- or TNF-/- mice conferred the same survival advantage on the M. tuberculosis-infected recipient mice, as the transfer of WT T cells. Therefore, memTNF, in the absence of soluble TNF, is sufficient to control acute, but not chronic, M. tuberculosis infection, in part through its expression on T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814712     DOI: 10.4049/jimmunol.174.8.4852

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling.

Authors:  Marisa I Gómez; Maghnus O Seaghdha; Alice S Prince
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

2.  Toxoplasma gondii inhibits toll-like receptor 4 ligand-induced mobilization of intracellular tumor necrosis factor alpha to the surface of mouse peritoneal neutrophils.

Authors:  Soumaya Bennouna; Woraporn Sukhumavasi; Eric Y Denkers
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.

Authors:  Roanne Keeton; Nasiema Allie; Ivy Dambuza; Brian Abel; Nai-Jen Hsu; Boipelo Sebesho; Philippa Randall; Patricia Burger; Elizabeth Fick; Valerie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

4.  Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon.

Authors:  Teresa M Wozniak; Bernadette M Saunders; Anthony A Ryan; Warwick J Britton
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

5.  Listeriosis in patients receiving biologic therapies.

Authors:  M Bodro; D L Paterson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-09       Impact factor: 3.267

6.  Differential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability.

Authors:  Mohammad Fallahi-Sichani; JoAnne L Flynn; Jennifer J Linderman; Denise E Kirschner
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

7.  Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection.

Authors:  Anthony A Ryan; Joanne M Spratt; Warwick J Britton; James A Triccas
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

Review 8.  Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.

Authors:  Takahiko Horiuchi; Hiroki Mitoma; Shin-ichi Harashima; Hiroshi Tsukamoto; Terufumi Shimoda
Journal:  Rheumatology (Oxford)       Date:  2010-03-01       Impact factor: 7.580

9.  Granulomatous disease in common variable immunodeficiency.

Authors:  Omür Ardeniz; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2009-08-28       Impact factor: 3.969

10.  Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.

Authors:  Nasiema Allie; Lena Alexopoulou; Valerie J F Quesniaux; Lizette Fick; Ksanthi Kranidioti; George Kollias; Bernhard Ryffel; Muazzam Jacobs
Journal:  Immunology       Date:  2008-06-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.